1. Cerebral Circulatory and Metabolic Disorders
This medicine is indicated for the treatment of cerebral circulatory insufficiency and cerebral metabolic disorders (cerebrovascular insufficiency) associated with the following symptoms:
- Cognitive decline and impaired alertness
- Dizziness, tinnitus, and headache
- Visual disturbances
- Memory impairment, anxiety, and depressive mood
- Inner ear-related hearing loss
- Impaired auditory and speech functions caused by vascular or metabolic cervical disorders
2. Peripheral Arterial Circulatory Disorders
This medicine is also indicated for the treatment of peripheral arterial circulatory disorders, including:
- Arteriosclerotic vascular disease
- Diabetic vascular damage (e.g., gangrenous conditions)
- Peripheral arterial occlusive disease (PAOD), including intermittent claudication
- Obliterative endarteritis
- Raynaud’s disease
- Other hormonal and neurovascular disorders
- Vascular diseases leading to nutritional impairment
Dosage and Administration
Usual Dosage: Administer 5–10 mL per day via intramuscular injection or intravenous injection, or 15 mL intravenously every two days.
- Acute Treatment: Administer 25 mL per day via intravenous injection or intravenous infusion.
- Severe Cases: Administer 25–50 mL per day via intravenous injection or intravenous infusion.
Shelf Life
36 months from the date of manufacture.
Storage
Store in a hermetic container at room temperature (1–30°C).